We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

12 hedge funds and large institutions have $18.3M invested in Champions Oncology in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

17,310% more capital inflows, than outflows

Capital inflows: $1.04M | Capital outflows: $6K

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

20% more funds holding

Funds holding: 10 → 12 (+2)

2.78% more ownership

Funds ownership: 56.28% → 59.06% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
5
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$525K
2
KCM
Knoll Capital Management
Florida
+$478K
3
Sandy Spring Bank
Sandy Spring Bank
Maryland
+$35.8K
4
JP Morgan Chase
JP Morgan Chase
New York
+$2.9K
5
UBS Group
UBS Group
Switzerland
+$1.3K

Top Sellers

Rank Fund Capital Flow
1
Alexandria Capital
Alexandria Capital
Virginia
-$6K

CSBR Hedge Fund Activity: Q4 2015 in Review

12 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q4 2015, worth a combined $18.3M — down 30% from $26.2M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CSBR positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $525K. The largest seller was Alexandria Capital, exiting entirely with an estimated $6K sold.

  • 12 institutional investors held Champions Oncology (CSBR) as of Q4 2015, up from 10 in Q3 2015.
  • Funds reported $18.3M of Champions Oncology stock for Q4 2015, down 30% quarter-over-quarter.
  • 3 funds opened new Champions Oncology positions in Q4 2015 and 1 closed out, a net change of +2 holders.
  • The largest Champions Oncology buyer in Q4 2015 was Sabby Management, an estimated $525K added.
  • The largest Champions Oncology seller in Q4 2015 was Alexandria Capital, an estimated $6K sold.

Based on aggregated 13F filings for Q4 2015.